Individualised selection of antihypertensive therapy

Area of Science:

• Cardiology
• Pharmacology

Background:

• Individualized treatment for hypertension is possible with numerous available drugs.
• Sequential stepped-care therapy is outdated; initial monotherapy is recommended.

Purpose of the Study:

• To guide the selection of first-line antihypertensive agents based on patient characteristics and drug properties.
• To review the evidence supporting initial monotherapy choices for hypertension management.

Main Methods:

• Review of available antihypertensive drug classes and their pharmacological/clinical properties.
• Analysis of outcome trials, particularly in the elderly population.
• Consideration of specific patient populations and comorbidities for drug selection.

Main Results:

• Diuretics and calcium antagonists are first-line options for elderly and Black patients.
• Beta-blockers are preferred for ischemic heart disease or high adrenergic drive.
• Alpha-blockers suit patients with lipid abnormalities or prostate issues.
• Calcium antagonists or ACE inhibitors are favored for quality of life and metabolic neutrality.
• Calcium antagonists are more effective than ACE inhibitors in high salt intake, Raynaud's, angina, and Black patients.
• ACE inhibitors are preferred for combination with diuretics, heart failure, or low salt intake.
• Both calcium antagonists and ACE inhibitors show potential in preventing ischemic ventricular fibrillation and atheroma.

Conclusions:

• Initial antihypertensive therapy selection should be tailored to individual patient needs and specific drug profiles.
• Combination therapy with calcium antagonists and ACE inhibitors is increasingly accepted due to theoretical benefits.